Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be reporting earnings tomorrow after the bell. Here’s what to look for. Collegium Pharmaceutical beat analysts’ revenue ...
Collegium Pharmaceutical Inc. is a specialty pharma company with strong cash flow, high EBITDA margins, and a focus on non-abusive painkillers and ADHD drugs. The new CEO has a proven track record ...
The Supreme Court Collegium on Thursday recommended the elevation of Justice Joymalya Bagchi, judge of the Calcutta High Court, to the apex court. The resolution of the Collegium stated that on ...
In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Collegium Pharmaceutical (COLL – Research Report), with a price target of $36.00. See what stocks are ...
Analysts on Wall Street project that Collegium Pharmaceutical (COLL) will announce quarterly earnings of $1.54 per share in its forthcoming report, representing a decline of 2.5% year over year.
The Neubauer Collegium for Culture and Society has announced nine new projects for 2025-26. Each year Collegium projects bring together University faculty and other researchers to work through ...
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...
NEW DELHI: The Health Ministry has called the AIIMS Director for the review of the collegium system implemented in the institute last year. The Union Ministry had implemented this system to check ...
Collegium Pharmaceutical (COLL) reported $181.95 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 21.5%. EPS of $1.77 for the same period compares ...
In this article, we are going to take a look at where Collegium Pharmaceutical, Inc. (NASDAQ:COLL) stands against the other small cap pharma stocks. Emily Field, Head of European Pharma Research ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
SC Collegium recommends Calcutta HC judge Joymala Bagchi's elevation. The elevation recommendation has raised doubts as SC Collegium bypassed several other senior judges. If cleared by the Centre, HC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results